HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees.

Abstract
Human adenovirus vectors containing intact or largely deleted E3 region were used to construct adenovirus-hepatitis B recombinant viruses (Ad-HepB) and shown to produce substantial amount of recombinant protein, hepatitis B surface antigen (HBsAg), in tissue culture. Previously we showed that these viruses were able to elicit good anti-HBs antibodies in a dog model. In the present study, the Ad-HepB viruses were evaluated for replication and immunogenicity in chimpanzees which sustain permissive infection by human adenoviruses. Recombinants containing entire E3 region showed better replication pattern than their E3 deleted counterparts as evidenced by longer duration and high titers of virus shedding. The effect of E3 region was also seen in the antibody titers against HBsAg in that the E3 containing viruses showed better response than the E3 deleted viruses. The importance of E3 region for the development of adenovirus vectored vaccines is further discussed.
AuthorsM V Chengalvala, B M Bhat, R A Bhat, S K Dheer, M D Lubeck, R H Purcell, K K Murthy
JournalVaccine (Vaccine) Vol. 15 Issue 3 Pg. 335-9 (Feb 1997) ISSN: 0264-410X [Print] Netherlands
PMID9139496 (Publication Type: Journal Article)
Chemical References
  • Adenovirus E3 Proteins
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Recombinant Fusion Proteins
Topics
  • Adenovirus E3 Proteins (genetics, immunology)
  • Adenoviruses, Human (genetics, immunology)
  • Animals
  • Genetic Vectors (immunology)
  • Hepatitis B Antibodies (biosynthesis)
  • Hepatitis B Surface Antigens (genetics, immunology)
  • Hepatitis B virus (genetics, immunology)
  • Humans
  • Pan troglodytes
  • Recombinant Fusion Proteins (immunology)
  • Virus Replication (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: